BioSpace News Archive

Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that members of the Aclaris management team will participate in a fireside chat during the Virtual SVB Securities Global Biopharma Conference on Tuesday, February 14, 2023 at 9:20 AM ET.

Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”) today announced financial results for its third fiscal quarter ended December 31, 2022.

PetVivo Holdings, Inc., an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, announces financial results for the third quarter of fiscal 2023.

Eliem Therapeutics, Inc., a biotechnology company focused on developing novel therapies for neuronal excitability disorders to address unmet needs in psychiatry, epilepsy, chronic pain, and other disorders of the peripheral and central nervous systems, provided a strategic business update and announced a leadership transition.

Alkermes plc will host a conference call and webcast presentation at 8:00 a.m. ET on Thursday, Feb. 16, 2023 to discuss the company’s fourth quarter and year-end 2022 financial results.

Wave Life Sciences Ltd. announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the SVB Securities Global Biopharma Conference at 10:00 a.m. ET on Thursday, February, 16, 2023.

Amgen (NASDAQ:AMGN) will present at the 2023 SVB Securities Global Biopharma Conference at 10:40 a.m. ET on Tuesday, February 14, 2023.

BIOLASE, Inc., the global leader in dental lasers, announced that the Company has been awarded a Top Workplaces 2022 honor by the Inland News Group.

Hyperfine, Inc., the groundbreaking medical device company that created the Swoop® system, the world’s first FDA-cleared portable MRI system, announced the presentation of new data regarding the use of the Swoop® system in stroke patient follow-up at the 2023 International Stroke Conference in Dallas, Texas.

This week, Theradaptive, a leading biotechnology company specializing in therapeutic delivery platforms, presents a new abstract demonstrating the efficacy and safety of the company’s novel AMP2 protein technology in rabbit PLF and sheep interbody fusion models.